The Sexual Satisfaction Scale (SSS)<\/strong> is a brief, specialized patient-reported outcome measure developed by the Consortium of Multiple Sclerosis Centers (CMSC) Health Services Research Subcommittee<\/a> as an integral subscale of the Multiple Sclerosis Quality of Life Inventory (MSQLI)<\/a>. Designed to evaluate subjective sexual well-being among individuals living with multiple sclerosis (MS)<\/a> and other chronic neurological conditions, the SSS addresses a critical yet historically underassessed domain of health-related quality of life (HRQoL<\/a>). The instrument comprises an initial dichotomous screening item assessing primary partner relationship status, followed by four evaluative items scored on a 6-point Likert-type scale ranging from 1 (Extremely Satisfied<\/em>) to 6 (Extremely Dissatisfied<\/em>). These core items assess physical affection, variety of sexual activities, overall personal sexual satisfaction, and perceived partner satisfaction over a 4-week recall window.<\/p>\n Psychometrically, the SSS demonstrates exceptional internal consistency (Cronbach\u2019s α typically ranging between .90 and .94) and robust test-retest reliability across 1- to 4-week reassessment intervals. Exploratory and confirmatory factor analyses support an essentially unidimensional latent construct representing global dyadic sexual satisfaction. The scale shows strong convergent validity with broader quality of life metrics, mental health indices, and relationship functioning scales, alongside established discriminant validity against unrelated physical disability measures. By capturing both personal appraisals and perceived dyadic mutuality, the SSS provides clinicians and clinical researchers with an efficient, reliable, and standardized assessment tool for tracking neurogenic sexual dysfunction, measuring response to multidisciplinary interventions, and identifying psychosocial vulnerabilities in chronically ill cohorts.<\/p>\n Sexual Satisfaction Scale, SSS, Multiple Sclerosis Quality of Life Inventory, MSQLI, sexual dysfunction, multiple sclerosis, psychometrics, health-related quality of life, dyadic sexual satisfaction, Consortium of Multiple Sclerosis Centers<\/p>\n The Sexual Satisfaction Scale (SSS) was developed under the auspices of the Consortium of Multiple Sclerosis Centers (CMSC) Health Services Research Subcommittee<\/strong> during the standardized construction of the Multiple Sclerosis Quality of Life Inventory (MSQLI) in the late 1990s. Key academic and clinical contributors to the development and psychometric validation of the MSQLI battery include:<\/p>\n Administrative and dissemination oversight was coordinated through the National Multiple Sclerosis Society (NMSS)<\/a> in New York, NY, which sponsored the developmental multi-center clinical trials establishing the battery.<\/p>\n Sexual health is an indispensable component of human psychological well-being, interpersonal intimacy, and overall quality of life. However, in populations managing progressive or chronic neurological illnesses such as multiple sclerosis, sexual difficulties are extraordinarily prevalent yet consistently underdiagnosed and undertreated. Pathophysiological disruptions within the central nervous system often impair autonomic, sensory, and motor pathways governing sexual arousal, lubrication, erection, and orgasm (primary sexual dysfunction). Simultaneously, secondary symptoms such as debilitating fatigue, muscle spasticity, neurogenic bowel and bladder incontinence, and chronic central neuropathic pain further impede sexual activity. Tertiary factors—including depression, altered body image, fear of partner rejection, and relational role changes—exacerbate psychosexual distress.<\/p>\n The primary purpose of the Sexual Satisfaction Scale (SSS) is to provide an empirically grounded, clinically viable, and psychometrically validated instrument specifically calibrated to detect and monitor subjective sexual satisfaction within this complex clinical context. Rather than focusing exclusively on mechanical or physiological capacities (such as erectile rigidity or vaginal lubrication, which are often captured by physiological inventories), the SSS focuses intentionally on the experiential and psychological appraisal of sexual well-being.<\/p>\n In clinical practice, the SSS serves several crucial functions:<\/p>\n The construct captured by the Sexual Satisfaction Scale is subjective sexual satisfaction within a dyadic relationship context<\/em>. Broadly conceptualized within psychometrics, sexual satisfaction is an affective and cognitive evaluation of the positive and negative aspects of an individual\u2019s sexual relationship. Rather than functioning as a mere proxy for sexual performance or coital frequency, it reflects an internal equilibrium between expectations, desires, physiological realities, and interpersonal outcomes. Within the SSS, this overarching construct is measured across four distinct evaluative facets anchored by a relational gateway:<\/p>\n The scale opens with a gatekeeper item: “Do you have a relationship with one primary partner?”<\/em> This dimension differentiates individuals navigating dyadic sexual encounters from those who are unpartnered. Because the subsequent evaluative items assess interactive and reciprocal sexual dynamics, respondents without a primary partner bypass the module, preventing erroneous missing-data imputation or uninterpretable scores.<\/p>\n This facet assesses satisfaction with the quantity and expression of non-coital and coital physical affection (e.g., hugging, caressing, kissing, tactile comfort). In individuals facing physical impairment, physical affection often becomes the central behavioral bridge maintaining intimacy when conventional sexual intercourse is limited by spasticity, sensory loss, or pain.<\/p>\n This dimension examines contentment with the variety of sexual activities shared with the partner. Chronic physical limitations frequently demand sexual adaptation, requiring couples to expand their repertoire beyond penetrative intercourse toward alternative erotic stimulation, tactile exploration, and assistive devices. Satisfaction with variety captures the dyad’s behavioral adaptability and erotic creativity.<\/p>\n This item captures the holistic, gestalt evaluation of the sexual relationship from the respondent’s internal perspective. It integrates emotional intimacy, sensory fulfillment, frequency of encounters, and personal expectations into an overarching cognitive appraisal of contentment.<\/p>\n Uniquely, the SSS evaluates the respondent’s perception of their partner’s contentment: “How satisfied do you think your partner has been with your sexual relationship in general?”<\/em> In chronic illness, anxiety concerning partner dissatisfaction or caregiver burden frequently engenders profound sexual guilt and withdrawal. Assessing perceived partner satisfaction directly measures the psychological construct of dyadic mutuality and empathic accuracy.<\/p>\n The construction of the SSS is anchored primarily within two theoretical traditions: the Medical Outcomes Study (MOS) Framework for Health-Related Quality of Life<\/strong> (Stewart & Ware, 1992<\/a>) and the Interpersonal Exchange Model of Sexual Satisfaction (IEMSS)<\/strong> (Lawrance & Byers, 1995<\/a>).<\/p>\n In developing the MSQLI, the Consortium of Multiple Sclerosis Centers adapted conceptual paradigms from the seminal Medical Outcomes Study conducted by Stewart, Ware, and colleagues. The MOS framework posits that health status cannot be understood solely through biological or physiological indices; rather, it manifests across multifaceted functional domains, including physical functioning, social role performance, emotional well-being, and bodily sensations. Sexual functioning was identified as an essential component of personal well-being. The MOS conceptual approach emphasizes that subjective patient appraisals often diverge sharply from objective disease markers, establishing patient-reported evaluations as the gold standard for quality of life measurement.<\/p>\n The IEMSS asserts that sexual satisfaction is governed by the balance of sexual rewards and sexual costs, comparisons against expected standards (Comparison Level), and perceived equality in the exchange of sexual rewards. The SSS reflects this theoretical model by pairing evaluations of direct sexual rewards (affection, variety, overall satisfaction) with evaluations of the partner’s perceived satisfaction. Dyadic systems theory further underpins Item 5, postulating that a partner’s perceived emotional state profoundly feeds back into the patient’s own sexual self-worth, particularly when chronic illness challenges traditional marital and sexual roles.<\/p>\n The psychometric validity of the SSS has been confirmed across multi-center instrument development cohorts, population-based registries, and independent epidemiological samples of individuals with demyelinating disease.<\/p>\n Construct validity is evidenced by moderate to strong correlations between the SSS and related psychological and somatic subscales within the MSQLI battery and the MOS 36-Item Short Form Survey (SF-36)<\/a>:<\/p>\n Discriminant validity is supported by weak or non-significant correlations with physically distant neurological impairments, such as visual acuity deficits measured by the Impact of Visual Impairment Scale (IVIS; $r < .15$<\/span>) and upper extremity motor scores. Furthermore, the SSS diverges sufficiently from purely somatic disability scales (such as the Expanded Disability Status Scale [EDSS]), proving that sexual satisfaction represents a distinct psychological construct not simply synonymous with physical disability.<\/p>\n The SSS demonstrates high internal consistency and temporal stability across clinical and research evaluations:<\/p>\n Across the four core evaluative items (Items 2 through 5), the scale demonstrates high internal consistency. In the definitive MSQLI standardization trials (Ritvo et al., 1997<\/a>; Fischer et al., 1999), Cronbach’s alpha coefficients ranged from .90 to .94<\/strong> across diverse cohorts. The item-total correlations for each of the four items consistently exceed .70, demonstrating that each item contributes substantial common variance to the overall score.<\/p>\n Temporal stability evaluated over a 30-day interval in clinically stable patients yields intraclass correlation coefficients (ICC) ranging between .78 and .85<\/strong>. This demonstrates that while the SSS reflects changes in response to therapeutic interventions or acute relationship shifts, it remains stable over time in the absence of exogenous changes.<\/p>\n The standard error of measurement (SEM) remains low relative to the scale\u2019s overall distribution, yielding high sensitivity to change and reliable clinical tracking across repeated consultations.<\/p>\n Extensive exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have examined the structural validity of the SSS.<\/p>\n Principal axis factoring and maximum likelihood extractions conducted on Items 2 through 5 consistently extract a single dominant factor<\/strong> with an eigenvalue exceeding 3.10, accounting for more than 75% to 82% of the total variance across clinical samples. Scree plot analyses demonstrate a definitive drop-off after the first component, verifying that a multidimensional structure is not warranted.<\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
1. Relational Eligibility and Context (Item 1)<\/h3>\n
2. Physical Affection (Item 2)<\/h3>\n
3. Behavioral Variety and Flexibility (Item 3)<\/h3>\n
4. Global Personal Sexual Satisfaction (Item 4)<\/h3>\n
5. Perceived Partner Satisfaction \/ Mutuality (Item 5)<\/h3>\n
6. Theoretical Framework<\/h2>\n
The Medical Outcomes Study (MOS) HRQoL Model<\/h3>\n
Interpersonal Exchange and Dyadic Systems Theory<\/h3>\n
7. Validity<\/h2>\n
Construct and Convergent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
Test-Retest Stability<\/h3>\n
Standard Error of Measurement<\/h3>\n
9. Factor Analysis<\/h2>\n
Exploratory Factor Analysis (EFA)<\/h3>\n